Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter NAPSA Antikörper (AA 189-299)

Der Kaninchen Monoklonal anti-NAPSA Antikörper wird verwendet zum Nachweis von NAPSA in Proben von Human, Ratte und Kaninchen. Er wurde validiert für IHC und WB.
Produktnummer ABIN6941166
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter NAPSA Antikörper (AA 189-299) (ABIN6941166)

Target

Alle NAPSA Antikörper anzeigen
NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 147
  • 19
  • 11
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Ratte, Kaninchen

Wirt

  • 76
  • 72
Kaninchen

Klonalität

  • 102
  • 46
Monoklonal

Konjugat

  • 70
  • 12
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Dieser NAPSA Antikörper ist unkonjugiert

Applikation

  • 106
  • 85
  • 45
  • 28
  • 19
  • 18
  • 12
  • 8
  • 7
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Western Blotting (WB)

Klon

NAPSA-1865R
  • Bindungsspezifität

    • 59
    • 9
    • 8
    • 6
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 189-299

    Verwendungszweck

    Recombinant Napsin A (Lung Adenocarcinoma Marker) Antibody

    Spezifität

    Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.

    Aufreinigung

    200ug/ml of recombinant MAb Purified by Protein A/G.

    Immunogen

    Recombinant human Napsin-A protein fragment (aa189-299) (exact sequence is proprietary)

    Isotyp

    IgG, kappa
  • Applikationshinweise

    Positive Control: Lung adenocarcinoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    NAPSA (Napsin A Aspartic Peptidase (NAPSA))

    Andere Bezeichnung

    NAPSA

    Hintergrund

    ASP4, Aspartyl protease 4, KAP, Kidney derived aspartic protease like protein (Kdap), NAP1, NAPA, Napsa, napsin A aspartic peptidase, Pronapsin A, SNAPA

    Lung adenocarcinoma, Lung, Kidney, K-562, HEK293, A549, Human Brain, Human Heart, Human Intestine, Human Kidney, Human Liver, Human Lung, Human Ovary, Human Pancreas, Human Prostrate, Human Skeletal Muscle, Human Skin, Human Spleen, Human Stomach, Human Testis

    Molekulargewicht

    37kDa

    Gen-ID

    9476, 512843

    UniProt

    O96009

    Pathways

    Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Sie sind hier:
Chat with us!